multiple-sclerosis

Documents about multiple-sclerosis

• Prefrontal Neurovascular Coupling Abnormalities Associated With Cognitive Performance in Multiple Sclerosis#676408Europe PMC
• A Cross-Sectional Study of MSDx Complex 1 as a Marker for Active Disease in Multiple Sclerosis#812551ClinicalTrials.gov
• The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis Cohort#813027ClinicalTrials.gov
• Efficacy of Diet on Quality of Life in Multiple Sclerosis#825478ClinicalTrials.gov
• Injection Management With Betaferon: Influence on Adherence, Patients Satisfaction and Health Related Outcomes (BETAPATH)#826989ClinicalTrials.gov
• Long-term Effect of Fingolimod on Circulating Immunocompetent Mononuclear Cells in Patients With Multiple Sclerosis#830862ClinicalTrials.gov
• A Phase IV Study of Dimethyl Fumarate Enteric-coated Capsules for Relapsing Multiple Sclerosis (RMS)#833480ClinicalTrials.gov
• Clinical Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Ponesimod in Patients With Relapsing-remitting Multiple Sclerosis#838069ClinicalTrials.gov
• First-in-Human Study With GNbAC1 in Healthy Volunteers#842754ClinicalTrials.gov
• Effect of High-Intensity Focused Electromagnetic Therapy on Balance and Quality of Life in Patients With Multiple Sclerosis#864202ClinicalTrials.gov
• Efficacy and Safety of Daclizumab in Participants With RRMS Switching From Natalizumab#873586ClinicalTrials.gov
• Promoting Physical Activity for Persons With Multiple Sclerosis#883213ClinicalTrials.gov
• A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis#906016ClinicalTrials.gov
• Use of Inertial Units in Patient With Multiple Sclerosis (IMUSEP)#906345ClinicalTrials.gov
• Study and Treatment of Visual Dysfunction and Motor Fatigue in Multiple Sclerosis#906918ClinicalTrials.gov
• Central Vein Sign: a Diagnostic Biomarker in Multiple Sclerosis#911767ClinicalTrials.gov
• Immunoadsorption vs. Plasmapheresis in the Escalation Therapy of Relapse in Multiple Sclerosis#913365ClinicalTrials.gov
• Efficacy Study of Adrenocorticotropin Hormone to Treat Multiple Sclerosis (MS) Relapses After Sub-responding to an Initial 3 Day Course of Intravenous (IV) Methylprednisolone#846343ClinicalTrials.gov
• Safety, Pharmacokinetics and Pharmacodynamics Study With 2B3-201 in Healthy Subjects and Multiple Sclerosis(MS) Patients#858505ClinicalTrials.gov
• Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1)#966387ClinicalTrials.gov
• Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-2)#967198ClinicalTrials.gov
• Tecfidera Slow-Titration Study#846216ClinicalTrials.gov
• De-escalating and discontinuing disease-modifying therapies in multiple sclerosis#7840HAL (France)
• Treatment Effects on Chronic Active Lesions in Multiple Sclerosis: Current Evidence and Future Perspectives#253593Europe PMC
• Digital Gait Analysis in the Home Environment of Patients With Multiple Sclerosis#804658ClinicalTrials.gov
• Teleconference Fatigue Management for People With Multiple Sclerosis#806814ClinicalTrials.gov
• Regional Non-comparative Prospective Study of the Impact of Gamma Knife Radiosurgery on Tremor in Multiple Sclerosis#807320ClinicalTrials.gov
• Prognostic Value of Three New Biomarkers of Multiple Sclerosis in Patients With Radiologically Isolated Syndrome#826441ClinicalTrials.gov
• EARLY IFNB-1a and Simvastatin Combination Therapy in Clinically Isolated Syndrome Suggestive of Multiple Sclerosis#831684ClinicalTrials.gov
• Monitoring of Patients Followed for a Multiple Sclerosis and Treated by Dimethyl-fumarate#833401ClinicalTrials.gov
• The Wearing-off Phenomenon of Ocrelizumab in Patients With Multiple Sclerosis#840681ClinicalTrials.gov
• Effect of Tysabri in Patients With Relapsing-Remitting Multiple Sclerosis: A Follow-up Magnetization Transfer Imaging (MTI) Study#846406ClinicalTrials.gov
• An Extension Study to Assess Impact of Multiple Sclerosis (MS) on Physical Function and Provide Continued Ocrelizumab Treatment#849780ClinicalTrials.gov
• Characterization of the Effects of Prolonged-release Fampridine on Ambulatory Function in Patients With Multiple Sclerosis#850919ClinicalTrials.gov
• TakeCharge: Telephone Delivered Self-management Intervention for People With Multiple Sclerosis (MS)#856625ClinicalTrials.gov
• Risk of Progressive Multifocal Leukoencephalopathy Among Patients With Multiple Sclerosis Exposed to Zeposia#866801ClinicalTrials.gov
• Multiple Sclerosis, Menstrual Cycle and Physical Acivity#873874ClinicalTrials.gov
• Tele-Assessment and Face-to-Face Evaluation of Functional Gait Assessment in Multiple Sclerosis#876253ClinicalTrials.gov
• Pharmacodynamic Study to Better Understand the Therapeutic Response and Immunomodulatory Effects of Avonex in Multiple Sclerosis (MS) Patients and Healthy Volunteers#877648ClinicalTrials.gov
• Multimodel Magnetic Resonance Imaging (MRI)of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders#881810ClinicalTrials.gov
• Evaluation and Neural Basis of Communication in Patients With Multiple Sclerosis#883749ClinicalTrials.gov
• Reliability and Validity of the Glittre Activities of Daily Living Test in Multiple Sclerosis Patients#884201ClinicalTrials.gov
• Is the Severity of Urinary Disorders Related to Falls in People With Multiple Sclerosis#888624ClinicalTrials.gov
• Mesenchymal Stem Cells in Multiple Sclerosis (MSCIMS)#889429ClinicalTrials.gov
• A Placebo Controlled Trial of Dalfampridine ER for Ambulatory Activity in People With Multiple Sclerosis#894964ClinicalTrials.gov
• Remote Exercise Effects on Cognitive Processing Speed in Multiple Sclerosis: A Pilot Trial#913085ClinicalTrials.gov
• Double Blind Combination of Rituximab by Intravenous and Intrathecal Injection Versus Placebo in Patients With Low-Inflammatory Secondary Progressive Multiple Sclerosis (RIVITaLISe)#810063ClinicalTrials.gov
• Using Optical Coherence Tomography (OCT) to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Patients With Relapsing Multiple Sclerosis#877341ClinicalTrials.gov
• Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria#7384OpenAlex
• Predicting multiple sclerosis from radiologically isolated syndrome using generative artificial intelligence#127895PLOS